Regulatory Mechanism of Collagen Degradation by Keratocytes and Corneal Inflammation: The Role of Urokinase-Type Plasminogen Activator

Abstract: Keratocytes, corneal resident cells in the corneal stroma, exist between collagen lamellae and maintain the corneal stromal structure. When the corneal stroma is damaged, keratocytes are transformed to myofibroblasts to aid corneal wound healing by phagocytizing debris. Keratocytes and extracellular collagen influence each other because keratocytes cultured in a 3D collagen gel undergo morphological changes and keratocytes produce metalloproteases that degrade extracellular collagen. IL-1 and plasminogen are critical mediators for collagen degradation. The plasminogen system contributes to tissue repair by activating matrix metalloproteinases (MMPs), releasing growth factors from the extracellular matrix and extracellular matrix degradation. Urokinase-type plasminogen activator (uPA) is thought to be involved in corneal disorders and regulates corneal wound healing. uPA is a serine protease synthesized by various cells such as corneal epithelial cells, corneal fibroblasts, vascular endothelial cells, smooth muscle cells, monocytes, macrophages, and malignant tumor cells of different origins. Here, we review the role of uPA in corneal stromal wound healing. uPA is expressed in leukocytes and corneal fibroblasts in the corneas of patients with corneal ulcerations suggesting it is a key regulator of corneal stromal wound healing. uPA is directly involved in plasmin-mediated collagen degradation induced by IL-1. Moreover, uPA is critically involved in promoting leukocyte infiltration in corneal inflammation by activating MMP-9. This activation is presumably directly and indirectly mediated by the plasminogen/plasmin cascade. Moreover, uPA mediates the release of inflammatory cytokines from corneal fibroblasts to promote leukocyte infiltration.

[1]  K. Sugioka,et al.  The roles of urokinase-type plasminogen activator in leukocyte infiltration and inflammatory responses in mice corneas treated with lipopolysaccharide. , 2014, Investigative ophthalmology & visual science.

[2]  K. Sugioka,et al.  Immunohistochemical localization of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and α2-antiplasmin in human corneal perforation: a case report , 2012, BMC Ophthalmology.

[3]  S. Lorenzl,et al.  Urokinase-Type Plasminogen Activator Promotes Paracellular Transmigration of Neutrophils Via Mac-1, But Independently of Urokinase-Type Plasminogen Activator Receptor , 2011, Circulation.

[4]  S. Rong,et al.  Renal Urokinase-Type Plasminogen Activator (uPA) Receptor but not uPA Deficiency Strongly Attenuates Ischemia Reperfusion Injury and Acute Kidney Allograft Rejection , 2008, The Journal of Immunology.

[5]  A. Bernstein,et al.  Urokinase receptor cleavage: a crucial step in fibroblast-to-myofibroblast differentiation. , 2007, Molecular biology of the cell.

[6]  A. Bernstein,et al.  Urokinase anchors uPAR to the actin cytoskeleton. , 2004, Investigative ophthalmology & visual science.

[7]  T. Nishida,et al.  Up-regulation of urokinase-type plasminogen activator in corneal epithelial cells induced by wounding. , 2003, Investigative ophthalmology & visual science.

[8]  P. Carmeliet,et al.  Receptor‐independent role of the urokinase‐type plasminogen activator during arteriogenesis , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  P. Carmeliet,et al.  uPAR: a versatile signalling orchestrator , 2002, Nature Reviews Molecular Cell Biology.

[10]  M. Nakamura,et al.  Stimulatory effect of pseudomonal elastase on collagen degradation by cultured keratocytes. , 2001, Investigative ophthalmology & visual science.

[11]  T. Standiford,et al.  Urokinase Receptor-Deficient Mice Have Impaired Neutrophil Recruitment in Response to Pulmonary Pseudomonas aeruginosa Infection1 , 2000, The Journal of Immunology.

[12]  K. Preissner,et al.  Urokinase Receptor (CD87) Regulates Leukocyte Recruitment via β2 Integrins In Vivo , 1998, The Journal of experimental medicine.

[13]  R. Goodman,et al.  Urokinase is required for the pulmonary inflammatory response to Cryptococcus neoformans. A murine transgenic model. , 1996, The Journal of clinical investigation.

[14]  T. Nishida,et al.  Role of Urokinase Type Plasminogen Activator (u-PA) in Corneal Epithelial Migration , 1993, Thrombosis and Haemostasis.

[15]  T. Nishida,et al.  Dexamethasone inhibition of phagocytosis by corneal keratocytes in culture. , 1988, Archives of ophthalmology.

[16]  T. Nishida,et al.  Fibronectin enhances the phagocytic activity of cultured rabbit keratocytes. , 1987, Investigative ophthalmology & visual science.

[17]  F. Blasi,et al.  Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors , 1987, The Journal of cell biology.

[18]  M. Nagpal,et al.  Phagocytic properties of human keratocyte cultures. , 1981, Investigative ophthalmology & visual science.

[19]  M. Berman,et al.  Evidence for a role of the plasminogen activator--plasmin system in corneal ulceration. , 1980, Investigative ophthalmology & visual science.

[20]  C. Marshall,et al.  Regulation of cell signalling by uPAR , 2010, Nature Reviews Molecular Cell Biology.

[21]  R. Berk,et al.  Characterization of arachidonic acid metabolism and the polymorphonuclear leukocyte response in mice infected intracorneally with Pseudomonas aeruginosa. , 1995, Investigative Ophthalmology and Visual Science.

[22]  R. Berk,et al.  Characterization of the inflammatory response induced by corneal infection with Pseudomonas aeruginosa. , 1994, Journal of ocular pharmacology.